Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Tina Nakonz
Long-Term Efficacy and Safety of Atazanavir/Ritonavir Treatment in a Real-Life Cohort of Treatment-Experienced Patients With HIV Type 1 Infection
AIDS Research and Human Retroviruses
Virology
Infectious Diseases
Immunology
Related publications
Pharmacokinetics of Etravirine Combined With Atazanavir/Ritonavir and a Nucleoside Reverse Transcriptase Inhibitor in Antiretroviral Treatment-Experienced, HIV-1-Infected Patients
AIDS Research and Treatment
Immunology
Public Health
Allergy
Environmental
Dermatology
Infectious Diseases
Occupational Health
Long-Term Safety and Effectiveness of Lopinavir/Ritonavir in Antiretroviral-Experienced HIV-1-infected Children
Archives of Disease in Childhood
Child Health
Pediatrics
Perinatology
Real-Life Study of Dual Therapy Based on Dolutegravir and Ritonavir-Boosted Darunavir in HIV-1-infected Treatment-Experienced Patients
PLoS ONE
Multidisciplinary
Genotypic Susceptibility Scores and HIV Type 1 RNA Responses in Treatment-Experienced Subjects With HIV Type 1 Infection
AIDS Research and Human Retroviruses
Virology
Infectious Diseases
Immunology
Lopinavir/Ritonavir in the Treatment of HIV-1 Infection: A Review
Therapeutics and Clinical Risk Management
Cost-Effectiveness of Atazanavir/Ritonavir Against Lopinavir/Ritonavir in the Treatment of People Living With Hiv in Peru
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Two-Year Safety and Virologic Efficacy of Maraviroc in Treatment-Experienced Patients With CCR5-Tropic HIV-1 Infection: 96-Week Combined Analysis of MOTIVATE 1 and 2
Journal of Acquired Immune Deficiency Syndromes
Infectious Diseases
Pharmacology
A Real-Life Data on the Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir + Dasabuvir +Ribavirin in Patients With Genotype 1 Chronic Hepatitis C Virus Infection in Serbia
Vojnosanitetski Pregled
Medicine
Pharmacology
Efficacy and Safety of Long-Term Treatment With Lenalidomide and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma
Blood Cancer Journal
Oncology
Hematology
